Tesamorelin activates the GHRH receptor
Once our local medical professionals approve your personalized treatment pathway, we provide flexible management options, including taking your weekly treatments home with regular virtual health check-ins
Compounded Medication Disclosure: all medications discussed in this article are compounded and are not FDA-approved
The weight reduction trajectories in the trial showed no plateau at 48 weeks, suggesting that longer treatment might yield even greater results
However, when combined with GLP-1 activity to keep glucose in check, the glucagon component drives increased energy expenditure through thermogenesis, enhanced fat oxidation and breakdown, improved metabolic rate, and potential additional central appetite regulation through pathways that neither GLP-1 nor GIP can access alone
The Precision Peptide Genetic Test reveals these predispositions, supporting a more informed conversation with your provider